Financhill
Back

Rocket Pharmaceuticals, Inc. Vs. Fate Therapeutics, Inc. Industry Stock Comparison

Sell
28

RCKT
Rocket Pharmaceuticals, Inc.

Last Price:
$3.52
Seasonality Move:
4.26%
Sell
34

FATE
Fate Therapeutics, Inc.

Last Price:
$0.98
Seasonality Move:
30.36%
Sell
28
Rocket Pharmaceuticals, Inc. (RCKT) is a Sell

Is Rocket Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.48. The Score for RCKT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Fate Therapeutics, Inc. (FATE) is a Sell

Is Fate Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Fate Therapeutics, Inc. [FATE] share price is $1.00. The Score for FATE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • FATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals, Inc.'s stock price today?

  • The Rocket Pharmaceuticals, Inc. share price today is $3.48
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing buying pressure, which is a positive indicator for future bullish movement.

FATE Stock Price Chart

What is Fate Therapeutics, Inc.'s stock price today?

  • The Fate Therapeutics, Inc. share price today is $1.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight buying pressure.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 54.12 Buy
Chaikin Money Flow: 720948 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.17 - 3.51) Buy
Bollinger Bands (100): (3.05 - 3.65) Buy

FATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 41.04 Sell
Chaikin Money Flow: -234058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.02 - 1.1) Sell
Bollinger Bands (100): (0.95 - 1.33) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.4 Buy
20-day SMA: 3.38 Buy
50-day SMA: 3.4 Buy
200-day SMA: 4.13 Sell
8-day EMA: 2.98 Buy
20-day EMA: 1.88 Buy
50-day EMA: 0.93 Buy
200-day EMA: 0.26 Buy

FATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.04 Sell
20-day SMA: 1.07 Sell
50-day SMA: 1.17 Sell
200-day SMA: 1.13 Sell
8-day EMA: 1.03 Sell
20-day EMA: 1.06 Sell
50-day EMA: 1.02 Sell
200-day EMA: 0.54 Buy

Rocket Pharmaceuticals, Inc. Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $0.73 per share.

Fate Therapeutics, Inc. Earnings Growth & FATE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.01 per share.

Rocket Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fate Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):